M Chimen University of Birmingham
Dr Myriam Chimen
Institute of Cardiovascular Sciences
Myriam is a post-doctoral Research fellow in Professor Ed Rainger group. She is interested in understanding the recruitment of leukocytes to endothelial cells during inflammation. Her PhD studies in the field lead to the identification of a novel immune regulatory pathway controlling the recruitment of T-lymphocytes during inflammation. This work has attracted a number of grants and awards including the Society for Endocrinology Early career grant.
Myriam’s current research focuses on exploring the role of platelet-monocyte interactions in the pathogenesis of atherosclerosis. Myriam is involved in organising meetings for the UK Adhesion Society.
- PhD, University of Birmingham (2012)
- Masters Biochemistry University of Toulouse, France (2008)
Myriam completed her undergraduate degree in Biochemistry at the University of Toulouse in France. She then completed her Masters in Biochemistry and Molecular Biology at the University of Toulouse where she developed a strong interest in immunology. She decided to move to Birmingham in the laboratory of Dr Parth Narendran and Prof Ed Rainger where she investigated the immune-modulatory effects of adipokines in type 1 diabetes. Myriam completed her PhD in 2012 where she discovered a novel peptide inhibitor of trans-endothelial migration (PEPITEM) and characterised this novel pathway in health and patients with type 1 diabetes.
Myriam has continued her post-doctoral training in Birmingham on the characterisation of the receptor for PEPITEM. Myriam has now embarked on her second post-doctoral position in the laboratory of Prof Ed Rainger where she is investigating the role of platelet-monocyte interactions in the pathogenesis of atherosclerosis. She is particularly interested in analysing the differential roles of the different monocytes subsets in atherosclerosis.